BENCH to BEDSIDE

Children’s Hospital of Philadelphia researchers are revolutionizing how clinicians treat patients via personalized precision medicine. In this new episode of the Bench to Bedside podcast, Susan Furth, MD, PhD, podcast host and Chief Scientific Officer, sits down with Stephan Kadauke, MD, PhD, Co-Director of the Cell Based Therapy Laboratory at CHOP, to discuss cell-based therapy, the global impact of the Cell Based Therapy Lab, and how the community helps with these efforts.

Children’s Hospital of Philadelphia researchers are revolutionizing how clinicians treat patients via personalized precision medicine. In this episode of the Bench to Bedside podcast, Susan Furth, MD, PhD, podcast host and Chief Scientific Officer at CHOP, talks with Paula Oliver, PhD, Co-chief of the Division of Protective Immunity, about the Core Facilities at CHOP Research Institute and how each uniquely works to elevate novel precision therapies.

How are researchers at Children's Hospital of Philadelphia revolutionizing pediatrics with the development of personalized medicine? In this episode, podcast host and CHOP's Chief Scientific Officer Susan Furth, MD, PhD, sits down with Joseph St. Geme III, MD, for an exciting chat about our pioneering work in cell and gene therapy and what the future may hold for children and young adults with complex, hard-to-treat diseases. 

The Morgan Center for Research and Innovation expands Children's Hospital of Philadelphia's state-of-the-art research environment. Chief Scientific Officer Dr. Susan Furth invited Audrey Odom John, MD, PhD, to discuss her involvement with planning her new lab space, and how new technologies and opportunities for collaboration will bolster her research within the Immunology and Infectious Diseases Research Initiative.

With an anticipated end-of-year opening of the 17-story, 350,000 square-foot Morgan Center for Research & Innovation, Dr. Sue Furth invited Donald Moore, senior vice president of CHOP’s Real Estate, Facilities, and Operations, to discuss how the project came to fruition, what researchers and the Philadelphia community can look forward to experiencing, and how Moore helped facilitate the project to its completion.

In the second installment of our Power of Philanthropy series, host Susan Furth, MD, PhD, Chief Scientific Officer at CHOP, chats with Laura Adang, MD, PhD, an attending physician in the Division of Neurology. Dr. Adang's research is grounded in years of learning, relationship-building, and collaboration with patients, families, and family-founded organizations who raise funds and awareness for research into leukodystrophies, a group of rare neurological disorders.

In the first part of our Bench to Bedside series focused on the transformative power of donations, gifts, and investments to support pediatric research, Monica Taylor Lotty, Children's Hospital of Philadelphia’s Chief Development Officer, shares the deeply heartfelt reasons behind philanthropy, which, at its core, “literally means love of humanity”.  

Learn more about how you can support children's health by contacting the CHOP Foundation: https://www.chop.edu/giving

Today’s high throughput sequencing techniques empower researchers to sequence a genome, epigenome, and transcriptome faster than ever before. At Children’s Hospital of Philadelphia Research Institute, Teodora Orendovici, PhD, Technical Director of the High Throughput Sequencing Core (HTS), is a passionate expert and leader devoted to ensuring all investigators, regardless of their research interests and goals, have access to the most advanced sequencing technologies. Accessibility and equity is critical, says Dr. Orendovici, if we are to develop a world where personalized medicine becomes possible for all patients. 

In the second part of our Explore the Cores series, Florin Tuluc, MD, PhD, Director of the Flow Cytometry Core Laboratory at CHOP Research Institute, sits down with host Susan Furth, MD, PhD, Chief Scientific Officer, to talk about what makes the Flow Lab a unique and valuable resource for the CHOP scientific community. Spoiler: It’s one-part state-of-the-art technology and two parts a team of incredible individuals with a passion for pediatric health.